Mount Sinai‑affiliated clinics in Manhattan are using an FDA‑cleared AI from BrightHeart to flag fetal heart abnormalities, a move studies show boosts detection and shortens review time.

Nobel laureate Richard Axel stepped down as co‑director of Columbia’s Zuckerman Institute after DOJ records linked him to Jeffrey Epstein. Columbia said it found no evidence of legal violations but accepted his resignation.

Forbes will stage its Under 30 Summit in Phoenix April 19–22, highlighting Arizona’s semiconductor, AI and startup momentum and a new local 30 Under 30 list.

Boulder-based Vero Networks closed a $500M growth equity round led by Hamilton Lane, Braemont and Delta‑v to fast‑track fiber builds and acquisitions.

Ubicquia closed a $106M Series D to speed AI for smart‑city sensors and analytics, led by 67 Capital and Marunouchi Innovation Partners.

UW and Princeton simulations map fallout scenarios and show Wisconsin at risk. The work arrives after New START expired on Feb. 5, 2026, renewing arms‑control concerns.

Washington University will add the 162‑year‑old St. Louis College of Pharmacy after the 2026‑27 year, keeping the program at the UHSP campus while approvals proceed.

Massachusetts plans to join the GUARDIAN newborn genome‑screening pilot that tests for 450+ treatable genetic conditions. The voluntary program would require state review before enrollment begins.

UC San Diego’s three‑hit model and international analyses link metabolic stress and parental chemical intolerance to autism risk, but experts urge caution. Larger trials are needed.

Raleigh startup Slate Medicines closed a $130M Series A to develop SLTE‑1009, an anti‑PACAP antibody for migraine prevention. The company plans a Phase 1 trial in mid‑2026.

Klaviyo co-founders Ed Hallen and Andrew Bialecki pledged $6 million to MIT’s delta v accelerator, boosting per-team funding and mentorship to help keep startups in Boston.

Livermore‑based Aalyria closed a $100M Series B at about a $1.3B valuation to scale its Spacetime orchestration software and Tightbeam laser terminals. Investors backed the spinout to speed commercial and government deployments.

Denver’s Xcimer says its KrF‑laser prototype could cut electricity costs and create hundreds of local jobs. The company has DOE backing and recent hardware milestones to show investors.